MedTrace Logo

Culturally Responsive Stress Reduction: A Mobile Mindfulness Application for African Americans (CRSR)

NCT04000841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2022-06-23

No results posted yet for this study

Summary

Over a 12-week period the investigators will test whether, compared to the Waitlist-Control (WC) condition, administration of the full CRSR intervention improves participants self-reported outcomes of stress, self-efficacy, mindfulness, use of mindfulness strategies, and knowledge. The investigators also will examine the usability, cultural relevance, and user satisfaction.

Conditions

  • Behavior

Interventions

BEHAVIORAL

Mindful You mobile app

The CRSR intervention consists of a native mobile application for Android and iOS devices. The mobile app includes: * Guided meditations of varying length designed to connect the user to the present moment and a place of calm through culturally aligned exercises grounded in spirituality, orality, self-empowerment, and resilience. * User-customized notifications prompting users to reflect and engage with the app, such as providing African American proverbs and quotes and asking simple questions like "What are you grateful for today?" * Scheduled messages on the importance mindfulness as a way increase control over physical and psychological health * User-customized reminders to do specific meditations and display personally selected images or messages.

Sponsors & Collaborators

  • Spelman College

    collaborator UNKNOWN

  • IRIS Media Inc

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-02-22
Completion
2022-02-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04000841 on ClinicalTrials.gov